Literature DB >> 15723964

Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives.

Feng J He1, Nirmala D Markandu, Rosemary Coltart, Jeffrey Barron, Graham A MacGregor.   

Abstract

Randomized trials have shown that increasing potassium intake lowers blood pressure. However, most previous trials used potassium chloride, whereas potassium in fruits and vegetables is not a chloride salt. It is unclear whether a nonchloride salt of potassium has a greater or lesser effect on blood pressure compared with potassium chloride. We performed a randomized crossover trial comparing potassium chloride with potassium citrate (96 mmol/d, each for 1 week) in 14 hypertensive individuals. At baseline, blood pressure was 151+/-16/93+/-7 mm Hg with a 24-hour urinary potassium of 81+/-24 mmol. During the randomized crossover part of the study, blood pressure was 140+/-12/88+/-7 mm Hg with potassium chloride (24-hour urinary potassium: 164+/-36 mmol) and 138+/-12/88+/-6 mm Hg with potassium citrate (24-hour urinary potassium: 160+/-33 mmol). These blood pressures were significantly lower compared with that at baseline; however, there was no significant difference in blood pressure between potassium chloride and potassium citrate, mean difference (95% confidence interval): 1.6 (-2.3 to 5.6) mm Hg for systolic and 0.6 (-2.4 to 3.7) mm Hg for diastolic. Our results, in conjunction with the evidence from many previous trials that potassium chloride has a significant blood pressure-lowering effect, suggest that potassium citrate has a similar effect on blood pressure as potassium chloride. These results support other evidence for an increase in potassium intake and indicate that potassium does not need to be given in the form of chloride to lower blood pressure. Increasing the consumption of foods high in potassium is likely to have the same effect on blood pressure as potassium chloride.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723964     DOI: 10.1161/01.HYP.0000158264.36590.19

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  Prehypertension: detection, evaluation, and management.

Authors:  Ross Pacini; Dhaval R Patel; Venkata Bavikati; Laurence S Sperling
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08

2.  Plasma bicarbonate and odds of incident hypertension.

Authors:  Ernest I Mandel; John P Forman; Gary C Curhan; Eric N Taylor
Journal:  Am J Hypertens       Date:  2013-08-13       Impact factor: 2.689

Review 3.  Dietary potassium and the renal control of salt balance and blood pressure.

Authors:  David Penton; Jan Czogalla; Johannes Loffing
Journal:  Pflugers Arch       Date:  2015-01-06       Impact factor: 3.657

4.  Blood pressure response to potassium supplementation is associated with genetic variation in endothelin 1 and interactions with E selectin in rural Chinese.

Authors:  May E Montasser; Lawrence C Shimmin; Donfeng Gu; Jing Chen; Charles Gu; Tanika N Kelly; Cashell E Jaquish; Treva Rice; D C Rao; Jie Cao; Jichun Chen; De-Pei Liu; Paul Whelton; Jiang He; James E Hixson
Journal:  J Hypertens       Date:  2010-04       Impact factor: 4.844

Review 5.  Non-pharmacological aspects of blood pressure management: what are the data?

Authors:  S Susan Hedayati; Essam F Elsayed; Robert F Reilly
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

6.  Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway.

Authors:  Satnam Lidder; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  Potassium softens vascular endothelium and increases nitric oxide release.

Authors:  H Oberleithner; C Callies; K Kusche-Vihrog; H Schillers; V Shahin; C Riethmüller; G A Macgregor; H E de Wardener
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

8.  Deletion of proton-sensing receptor GPR4 associates with lower blood pressure and lower binding of angiotensin II receptor in SFO.

Authors:  Xuming Sun; Ellen Tommasi; Doris Molina; Renu Sah; K Bridget Brosnihan; Debra Diz; Snezana Petrovic
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-28

9.  Rationale and Design of a Randomized Placebo-Controlled Clinical Trial Assessing the Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease.

Authors:  Martin Gritter; Liffert Vogt; Stanley M H Yeung; Rosa D Wouda; Christian R B Ramakers; Martin H de Borst; Joris I Rotmans; Ewout J Hoorn
Journal:  Nephron       Date:  2018-06-29       Impact factor: 2.847

10.  DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.

Authors:  Y Al-Solaiman; A Jesri; W K Mountford; D T Lackland; Y Zhao; B M Egan
Journal:  J Hum Hypertens       Date:  2009-07-23       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.